These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37958848)

  • 1. Transfection of Vein Grafts with Early Growth Response Factor-1 Oligodeoxynucleotide Decoy: Effects on Stem-Cell Genes and Toll-like Receptor-Mediated Inflammation.
    Mylonas KS; Peroulis M; Kapelouzou A
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
    Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ex-vivo gene therapy of vein grafts with Egr-1 decoy in the suppression of intimal hyperplasia.
    Peroulis M; Kakisis J; Kapelouzou A; Giagini A; Giaglis S; Mantziaras G; Kostomitsopoulos N; Karayannacos P; Macheras A
    Eur J Vasc Endovasc Surg; 2010 Aug; 40(2):216-23. PubMed ID: 20537569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of gene therapy with a cyclic adenosine monophosphate response element decoy oligodeoxynucleotide to prevent vascular intimal hyperplasia.
    Uchida D; Saito Y; Kikuchi S; Yoshida Y; Hirata S; Sasajima T; Azuma N
    J Vasc Surg; 2020 Jan; 71(1):229-241. PubMed ID: 31204215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo reduction of the nuclear factor-kappaB activity using synthetic cis-element decoy oligonucleotides suppresses intimal hyperplasia in the injured carotid arteries in rabbits.
    Takeuchi K; Itoh H; Yonemitsu Y; Matsumoto T; Kume M; Komori K; Maehara Y
    Surg Today; 2007; 37(7):575-83. PubMed ID: 17593477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative transfection of vein grafts with the NFkappaB decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia.
    Shintani T; Sawa Y; Takahashi T; Matsumiya G; Matsuura N; Miyamoto Y; Matsuda H
    Ann Thorac Surg; 2002 Oct; 74(4):1132-7; discussion 1137-8. PubMed ID: 12400757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.
    Miyake T; Aoki M; Morishita R
    Cardiovasc Res; 2008 Sep; 79(4):706-14. PubMed ID: 18515844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on vein graft intimal hyperplasia of nuclear factor-kB decoy transfection using the second generation of HVJ vector.
    Shimizu N; Azuma N; Nishikawa T; Hirata S; Morishita R; Kaneda Y; Sasajima T
    J Cardiovasc Surg (Torino); 2007 Aug; 48(4):463-70. PubMed ID: 17653006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Expression of Pluripotency, Longevity, and Proinflammatory Genes in the Context of Hypercholesterolemia and Statin Treatment.
    Mylonas KS; Peroulis M; Kapetanakis EI; Kapelouzou A
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610757
    [No Abstract]   [Full Text] [Related]  

  • 11. c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins.
    Ni J; Waldman A; Khachigian LM
    J Biol Chem; 2010 Feb; 285(6):4038-4048. PubMed ID: 19940138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat.
    Han W; Liu GN
    Life Sci; 2010 Feb; 86(7-8):234-43. PubMed ID: 20025889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
    el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
    Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A
    J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
    Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
    J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F decoy oligodeoxynucleotides on neointimal hyperplasia in canine vein graft.
    Cho WH; Lee SO; Kim HT; Ahn JD; Lee IK
    Transplant Proc; 2005; 37(1):77-9. PubMed ID: 15808553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor.
    Luo Z; Asahara T; Tsurumi Y; Isner JM; Symes JF
    J Vasc Surg; 1998 Jan; 27(1):167-73. PubMed ID: 9474095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
    Mann MJ; Whittemore AD; Donaldson MC; Belkin M; Conte MS; Polak JF; Orav EJ; Ehsan A; Dell'Acqua G; Dzau VJ
    Lancet; 1999 Oct; 354(9189):1493-8. PubMed ID: 10551494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neointimal hyperplasia after balloon injury by cis-element 'decoy' of early growth response gene-1 in hypercholesterolemic rabbits.
    Ohtani K; Egashira K; Usui M; Ishibashi M; Hiasa KI; Zhao Q; Aoki M; Kaneda Y; Morishita R; Takeshita A
    Gene Ther; 2004 Jan; 11(2):126-32. PubMed ID: 14712296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.